Cargando…

Long-Term Survival With Pembrolizumab Re-administration After Pseudo-Progression With Immune-Related Interstitial Lung Disease in a Patient With Non-small Cell Lung Cancer

Immune checkpoint inhibitors may cause specific immune-related reactions, such as pseudo-progression. In particular, malignant pleural effusion tends to worsen due to this phenomenon. However, the appropriate management in such cases is unclear. We report a 73-year-old man with advanced lung adenoca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakashima, Koki, Demura, Yoshiki, Akai, Masaya, Ishizuka, Tamotsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8338124/ https://www.ncbi.nlm.nih.gov/pubmed/34367784 http://dx.doi.org/10.7759/cureus.16177

Ejemplares similares

Whole-brain Radiation and Pembrolizumab Treatment for a Non-small-cell Lung Cancer Patient with Meningeal Carcinomatosis Lacking Driver Oncogenes Led to a Long-term Survival
por: Nakashima, Koki, et al.
Publicado: (2020)

Successful Re-administration of Atezolizumab for a Non-small-cell Lung Cancer Patient after Cardiac Tamponade Development as a Manifestation of Pseudo-progression Induced by Combination Treatment with Atezolizumab and Cytotoxic Chemotherapy
por: Nakashima, Koki, et al.
Publicado: (2021)

Xanthomatous Pleuritis Associated With Pancreaticopleural Fistula
por: Nakashima, Koki, et al.
Publicado: (2022)

Utility of Endoscopic Ultrasound with Bronchoscope-guided Fine-needle Aspiration for Detecting Driver Oncogenes in Non-small-cell Lung Cancer during Emergency Situations: Case Series
por: Nakashima, Koki, et al.
Publicado: (2020)

Successful treatment with lorlatinib in a patient with meningeal carcinomatosis of ALK-positive non-small cell lung cancer resistant to alectinib and brigatinib: A case report
por: Nakashima, Koki, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the Literature
por: Nakashima, Koki, et al.
Publicado: (2022)

Efficacy and safety of nanoparticle albumin‐bound paclitaxel monotherapy after immune checkpoint inhibitor administration for advanced non‐small cell lung cancer: A multicenter Phase 2 clinical trial
por: Sonoda, Tomoaki, et al.
Publicado: (2023)

Infliximab Was Found to Be Effective for Treating Immunosuppressive Drug-resistant Hepatitis due to Durvalumab
por: Nakashima, Koki, et al.
Publicado: (2020)

The Association between Malignant Pleural Mesothelioma and Thoracic Radiation Therapy for Hodgkin's Lymphoma: The First Case Report in Japan
por: Nakashima, Koki, et al.
Publicado: (2020)

Efficacy and safety of nivolumab in non‐small cell lung cancer with preexisting interstitial lung disease
por: Kanai, Osamu, et al.
Publicado: (2018)

Safety and utility of Endoscopic Ultrasound with Bronchoscope-guided Fine Needle Aspiration (EUS-B-FNA) in suspected lung cancer patients with poor respiratory or general conditions: a prospective three-center observational study
por: Nakashima, Koki, et al.
Publicado: (2023)

Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy as second-line therapy of cytotoxic anticancer drugs in patients with advanced non-small cell lung cancer
por: Anzai, Masaki, et al.
Publicado: (2017)

Seeds in the Lungs: A Pseudo-Miliary Pattern of Sarcoidosis
por: Khanal, Subrat, et al.
Publicado: (2022)

Metformin-Induced Eosinophilic Interstitial Lung Disease
por: Alyami, Sami M, et al.
Publicado: (2023)

Recent Advances in the Treatment of Interstitial Lung Diseases
por: Bang, Aneesh A, et al.
Publicado: (2023)

Talaromycosis in a Patient on Nintedanib for Interstitial Lung Disease
por: Madgula, Anantha Sriharsha, et al.
Publicado: (2020)

Clinically Amyopathic Dermatomyositis With Rapid Progressive Interstitial Lung Disease Diagnosed in a Patient on Extracorporeal Membrane Oxygenation
por: Al-Husayni, Faisal, et al.
Publicado: (2022)

A case of non-small cell lung cancer presenting anti-amphiphysin antibody-positive paraneoplastic neurological syndrome
por: Nakashima, Koki, et al.
Publicado: (2021)

A case of interstitial lung disease with alveolar hemorrhage induced by pembrolizumab
por: Sugano, Teppei, et al.
Publicado: (2018)

Mycobacterium tuberculosis Infection in the Setting of Interstitial Lung Disease: Coincidence or Bad Luck?
por: Wong, Christian, et al.
Publicado: (2018)

Association of Celiac Disease With Pembrolizumab
por: Sethi, Ashish, et al.
Publicado: (2021)

Pulmonary hypertension due to unclassified interstitial lung disease in a Pembroke Welsh corgi
por: MORITA, Tomoya, et al.
Publicado: (2018)

Anti-Synthetase Syndrome-Related Interstitial Lung Disease With Anti-PL-12 Antibodies
por: Elferjani, Belqis, et al.
Publicado: (2021)

Interstitial Lung Disease and Transverse Myelitis: A Possible Complication of COVID-19 Vaccine
por: Khan, Zunaira, et al.
Publicado: (2022)

Mortality and Its Predictors in COVID-19 Patients With Pre-existing Interstitial Lung Disease
por: Dutt, Naveen, et al.
Publicado: (2022)

Pembrolizumab for Previously Untreated Patients with Advanced Non-small-cell Lung Cancer and Preexisting Interstitial Lung Disease
por: Fujita, Tetsuo, et al.
Publicado: (2020)

The Prevalence of Pulmonary Embolism in Patients With Interstitial Lung Disease: A Cross-Sectional Retrospective Study
por: Alsilmi, Rahmah
Publicado: (2022)

Platinum-doublet chemotherapy followed by pembrolizumab therapy for lung cancer with lymphangitis carcinomatosa mimicking interstitial pneumonitis: A case report
por: Yamasaki, Masahiro, et al.
Publicado: (2019)

Bleomycin-Induced Lung Injury After Intravenous Iron Administration
por: Saccone, Nicole, et al.
Publicado: (2022)

A Case of Rheumatoid Arthritis-Associated Interstitial Lung Disease - An Unfortunate Complication of Untreated Rheumatoid Arthritis!
por: Ruggiero, Raffaele A, et al.
Publicado: (2020)

Systemic Sclerosis Associated Interstitial Lung Disease and Nintedanib: A Rare Disease and a Promising Drug
por: Kafle, Sunam, et al.
Publicado: (2021)

An Unusual Association of Idiopathic Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) With Interstitial Lung Disease (ILD)
por: Saha, Shubhashis, et al.
Publicado: (2023)

Works in Progress: Using Administrative Data to Estimate the Prevalence of Progressive Fibrosing Interstitial Lung Disease
por: Bowman, Willis S., et al.
Publicado: (2022)

Pembrolizumab‐induced interstitial lung disease following thoracic surgery in a patient with non‐small cell lung cancer
por: Fujita, Tetsuo, et al.
Publicado: (2019)

Acute Pancreatitis Secondary to Pembrolizumab-Induced Hypertriglyceridemia
por: Ashfaq, Ammar, et al.
Publicado: (2023)

A Case of Pseudo-Pseudo Meigs’ Syndrome Despite Optimized Immunosuppressive Therapy for Systemic Lupus Erythematosus
por: Dang, Varun, et al.
Publicado: (2023)

The Effect of Pembrolizumab in Absence of Programmed Death 1 Receptor
por: Al Attar, Layth, et al.
Publicado: (2018)

Role of High-Resolution CT Thorax in Diagnosing Interstitial Lung Disease and Its Association With Smoking and Connective Tissue Disorder
por: Doshi, Jainam A, et al.
Publicado: (2022)

Chronic Idiopathic Intestinal Pseudo-Obstruction
por: Piao, Xuanzhen, et al.
Publicado: (2021)

Progression of fibrosing interstitial lung disease
por: Wong, Alyson W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hjdnhb5o0db7hn15rthn5mg818